Tandem Diabetes stockholders approve 3M-share increases to ESPP and LTIP at annual meeting

TANDEM DIABETES CARE INC

Stockholders elected all 9 director nominees; highest vote count for John Sheridan (50.3M for).
Approved amendment to 2013 ESPP to increase authorized shares by 3,000,000; 50.4M for, 117,501 against.
Approved amendment to 2023 LTIP to increase authorized shares by 3,000,000; 47.6M for, 3.0M against.
Advisory say-on-pay approved: 47.9M for, 2.3M against, 299,108 abstain.
Ratified Ernst & Young as independent auditor for FY 2024: 53.2M for, 1.4M against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.